Insight

Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Photo taken from Megan E. Tesch/X

Aug 3, 2024, 06:00

Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Megan E. Tesch, Medical oncologist at Dana-Farber Cancer Institute, shared on X:

“What are the clinical implications of incomplete ovarian function suppression? In this study we evaluate estrogen levels in young patients on OFS treatment for breast cancer with ultrasensitive assays and correlate with outcomes.

‘Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy‘

Authors: Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, Philip D. Poorvu, Kathryn J. Ruddy, Rulla Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia Borges, Steven E. Come, Craig Snow, Shalender Bhasin Ann H. Partridge.⁦”

Source: Megan E. Tesch/X

Breast Cancer cancer Craig Snow Jeffrey Peppercorn Kathryn J. Ruddy Lidia Schapira Megan E. Tesch OncoDaily Oncology Philip D. Poorvu Rulla Tamimi Shalender Bhasin Ann H. Partridge Shoshana M. Rosenberg Steven E. Come Virginia Borges Yue Zheng

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Special Coverage